Mount Sinai Health System and IBM Research Launch Effort That Leverages Artificial Intelligence and Behavioral Data to Improve Mental Health Care for Young People

FOR IMMEDIATE RELEASE
Media Contact: Elizabeth Dowling
Mount Sinai Press Office
347-541-0212
[email protected] 

Mount Sinai Health System and IBM Research Launch Effort That Leverages Artificial Intelligence and Behavioral Data to Improve Mental Health Care for Young People

Newswise — New York, NY (September 12, 2024) – Mount Sinai Health System and IBM Research today announced the launch of the Phenotypes Reimagined to Define Clinical Treatment and Outcome Research (PREDiCTOR) study. The research effort aims to address the lack of objective measures in psychiatry by leveraging advances in artificial intelligence and incorporating rich behavioral data from clinical interviews, at-home data captured on smartphones, and cognitive testing. The goal is to predict outcomes such as treatment discontinuation, hospitalizations, and emergency room visits for young people who are seeking mental health evaluation and treatment. The study will be conducted in collaboration with researchers from Harvard, Johns Hopkins, Columbia, and Carnegie Mellon universities and Deliberate AI.

Funded by a $20 million grant from the National Institute of Mental Health (NIMH), the PREDiCTOR study brings together a team of leading clinical investigators, artificial intelligence experts, and data scientists. The team will use objective, scalable, and cost-effective measurements to define novel clinical signatures that can be used for individual-level prediction and clinical decision-making in treating mental health disorders.

The research project will be co-led by Rene Kahn, MD, PhD, Chair of Psychiatry at the Icahn School of Medicine at Mount Sinai and Mount Sinai Health System; Cheryl Corcoran, MD, Program Leader in Psychosis Risk for Icahn Mount Sinai; and Guillermo Cecchi, PhD, Director of the Computational Psychiatry and Neuroimaging groups in IBM Research. Collaborators from Harvard, Johns Hopkins, Columbia, and Carnegie Mellon universities and Deliberate.ai will contribute to the work as well.

“Every clinical visit provides a wealth of untapped behavioral data that includes spoken language, eye contact, and facial expressions from both the patient and clinician,” says Dr. Corcoran, Associate Professor of Psychiatry at Icahn Mount Sinai. “With advancements in computational approaches, these behaviors can be operationalized and quantified through analysis of audiovisual data obtained from the recording of clinical interviews. Coupled with valid behavioral data derived from smartphones that track physical activity metrics like step count and distance traveled, geolocation, social interactions like text messages and phone calls, sleep patterns, and audio data from diaries, we can develop clinical signatures that are indicative of key outcomes.”

The team will develop novel clinical signatures in patients aged 15 to 30 years who seek treatment for the first time at one of six outpatient mental health clinics within the Mount Sinai Health System. These clinics serve an ethnically diverse community from various socioeconomic backgrounds and this particular age range represents a developmental window during which many disturbances of thought, emotion, and behavior emerge and when diagnoses and prognoses are often still unclear.

“Individualized prognosis and clinical decision-making during this critical period may have a profound impact on the lifetime trajectory of these young patients,” said Dr. Kahn, the Esther and Joseph Klingenstein Professor of Psychiatry at Icahn Mount Sinai. “Our team possesses longstanding expertise in electronic health record analysis, audiovisual behavior collection, and computational analysis of these data. We also have extensive involvement in community engagement and a strong track record of collaboration, making us uniquely poised to carry out this important work.”

The study team will invite all new patients, irrespective of their initial diagnosis, to have audio and visual recordings made of their clinical visits over one year. Cognitive function, as one of the most robust and well-established general predictors of outcome, will be assessed at baseline, and patients will be assessed over the one-year period. By analyzing these rich behavioral datasets from routine clinical visits and smartphones, the team will develop clinical signatures for particularly clinically relevant events (outcomes) in young help-seeking people, namely treatment disengagement, emergency room visits and hospitalizations.

“Our goal is to gain a better understanding of what predicts whether young people stay in mental health treatment or drop out, and what predicts whether their symptoms worsen such that they need acute care in an emergency crisis center or hospital,” said Dr. Cecchi. “We have shown in our research that artificial intelligence can be used to predict some outcomes in controlled experimental settings, but we believe that current advancements are powerful enough to be applied in the context of usual clinical practice.”   

This research effort is supported by the NIMH’s Individually Measured Phenotypes to Advance Computational Translation in Mental Health program, a new initiative focused on using behavioral measures and computational methods to define novel clinical signatures that can be used for individual-level prediction and clinical decision making in treating mental disorders. The importance of this new NIMH program was highlighted in a recent news update issued by the White House Office of Science and Technology.

About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2024-2025.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

###